Request Discount

Psoriasis Therapeutics Market (Molecule Type - Biologics, and Small Molecules; Route of Administration - Oral, Parenteral, and Topical; Dosage - TNF Inhibitors, Pde4 Inhibitors, Interleukin Blockers, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2028

  • Published : May, 2022

  • Rep Id : HC0146

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the psoriasis therapeutics market provides an in-depth analysis of segments and sub-segments in the global as well as regional psoriasis therapeutics market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional psoriasis therapeutics market over the short term as well as long term. The report is a comprehensive presentation of trends, forecasts, and dollar values of the global psoriasis therapeutics market. According to the report, the global psoriasis therapeutics market is projected to grow at a CAGR of 9% over the forecast period of 2022-2028. The revenue generated by the psoriasis therapeutics market was approximately USD 24 billion in 2022 and is expected to reach approximately USD 44 billion in 2028.

 

Market Insight

The psoriasis therapeutics market is projected to register with a CAGR of 9% during the forecast period. Psoriasis is a chronic inflammatory skin condition that is often connected with our systematic manifestation. This genetic condition may or may not be present at birth, but genetic and environmental factors could also trigger it. Psoriasis is a non-contagious autoimmune skin disease characterized by red scaly patches forming on the affected area. This condition causes skin cells to grow fast and cause a rapid build-up of thick scaly patches on the surface of the skin. Moreover, the skin cells' cycle is disturbed, due to which new cells under the skin grow and surface quickly to form itchy patches known as "plaques". Symptoms worsen during the winter season, and sufferers can experience allergic reactions to medicines, infections, or even psychological stress. Diagnosis of psoriasis is typically based on signs and symptoms. Generally, it was thought to be a genetic disease triggered by pollution. The etiology of this disease is unknown; however, it is said that overactivity of the immune system can cause widespread inflammation, thereby resulting in the flaking of skin and forming red, white, or silvery patches. However, the unknown etiology of this disease is the major factor hampering the growth of the market. n addition, government initiatives for research and development (R&D) of the disease and cures, and favorable reimbursement policies will further fuel the growth of this market over the forecast period.

 

COVID-19 was an incomparable global public health emergency that has affected almost every industry and is projected to impact these various industry growths during the forecast period. During the Covid-19, pandemic people were compelled to stay in their homes. The governments of many countries in the world turned their focus to healthcare from other industries. The epidemic has positively affected the global psoriasis therapeutics market. The global COVID-19 pandemic has been unprecedented and staggering, with psoriasis treatment experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The significant growth was due to an increase in key players' revenues, higher demand for psoriasis treatment, increasing investment in research & development of new drugs, and others.

 

A skin disorder that is considered mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal, such disorder is known as psoriasis. Psoriasis varies in rigorousness from small, localized patches to complete body coverage. The body parts such as knees, elbows, and scalp are major get affected by psoriasis. The therapy for this disease is to stop the skin cells from developing so quickly. The therapeutic approach for psoriasis depends upon the amount of skin affected by this disorder. Radiation therapy in severe cases is used to treat psoriasis. Topical treatments, injecting steroids, and internal medicine are other treatment methods for psoriasis. The demand for psoriasis therapeutics is increasing worldwide, due to the rising incidence of psoriasis with skin disorders. In addition, increasing awareness among people relating to different treatments available in the market is likely to boost the growth of the market. On the other hand, high costs of therapies are likely to hamper the growth of the market. Furthermore, the cumulative development of new biologics and new pipeline drugs will bring more opportunities to this market.

 

The report provides a regional outlook covering geographies such as North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the command over the global psoriasis therapeutics market and is expected to dominate the overall market during the forecast period. The rising burden of this condition in the region and increasing initiatives to raise awareness among the general population are anticipated to boost the demand for effective treatment options for managing the condition. For instance, every year in August, Psoriasis Awareness Month is organized in the U.S. to educate and inform patients about the diagnosis and treatment options for this disorder. The region is expected to maintain its dominance during the forecast period. The dominance is attributed to the higher adoption of advanced treatment therapies, increasing research and development spending by the players in the region on clinical trials for psoriasis treatment, and increasing long-term & preventive healthcare facilities. Europe and the Asia Pacific are followed next after North America owing to the presence of a diversified patient pool, emerging economies, and a rise in the collaboration of domestic and international companies in these regions, thus driving this market.


Psoriasis Therapeutics Market

 

Segment Covered

The report on the global psoriasis therapeutics market covers segments such as molecule type, route of administration, and dosage. On the basis of molecule type, the sub-markets include biologics and small molecules. On the basis of route of administration, the sub-markets include oral, parenteral, and topical. On the basis of dosage, the sub-markets include TNF inhibitors, pde4 inhibitors, interleukin blockers, and others.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche, GlaxoSmithKline plc, Merck and Co., Inc., Valeant Pharmaceuticals International, Inc., Biocon Limited, Eli Lilly and Company, and G and W Laboratories Inc.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors driving and restraining this market's growth. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the psoriasis therapeutics market. Moreover, the study highlights current market trends and provides forecasts for 2022-2028. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount